We are live on ! Find out more
ENGN icon

enGene Therapeutics

Name Holding Trade Value Shares
Change
Change in
Stake
FIS
1
FCPM III Services
Netherlands
$65.8M
VA
2
VR Adviser
New York
$34.5M
KCM
3
Kynam Capital Management
New Jersey
$34.1M
BOCH
4
Blue Owl Capital Holdings
New York
$22.4M -$2.05M -450,000 -12%
CAM
5
Cormorant Asset Management
Massachusetts
$15.9M
B
6
Braidwell
Connecticut
$15.5M +$10.3M +2,266,319 New
DTC
7
Deep Track Capital
Connecticut
$15.3M -$10.6M -2,318,222 -51%
PA
8
Perceptive Advisors
New York
$14.3M +$9.56M +2,097,236 New
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$8.25M +$456 +100 +0%
FLSM
10
Frazier Life Sciences Management
California
$7.9M +$5.28M +1,157,380 New
Franklin Resources
11
Franklin Resources
California
$7.09M
Adage Capital Partners
12
Adage Capital Partners
Massachusetts
$6.83M
SOCM
13
SR One Capital Management
Pennsylvania
$5.11M
Bank of America
14
Bank of America
North Carolina
$4.42M -$6.19M -1,358,516 -68%
MB
15
MPM BioImpact
Massachusetts
$3.62M +$2.42M +530,299 New
OFM
16
Omega Fund Management
Massachusetts
$3.6M
SFM
17
Sphera Funds Management
Israel
$3.45M
Morgan Stanley
18
Morgan Stanley
New York
$2.97M +$376K +82,523 +23%
VPC
19
Vestal Point Capital
New York
$2.53M
Marshall Wace
20
Marshall Wace
United Kingdom
$2.35M
Goldman Sachs
21
Goldman Sachs
New York
$1.01M -$3.43M -751,484 -84%
AAA
22
Affinity Asset Advisors
New York
$526K
Citadel Advisors
23
Citadel Advisors
Florida
$399K +$161K +35,327 +153%
Northern Trust
24
Northern Trust
Illinois
$207K -$12.5K -2,731 -8%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$198K